Approval · Notice of Compliance 5486 · 1994
ACCUPRIL: Notice of Compliance 5486
Issued October 25, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5486
- Date
- October 25, 1994
- Company
- Parke-Davis Division, Warner-Lambert Canada Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACCUPRIL | Not yet assigned | — |
Medicinal ingredients
- QUINAPRIL HCL 5 MG per TAB
- QUINAPRIL HCL 10 MG per TAB
- QUINAPRIL HCL 20 MG per TAB
- QUINAPRIL HCL 40 MG per TAB